title: Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria.
abstract: In non-insulin-dependent diabetes mellitus (NIDDM) patients, microalbuminuria predicts early mortality, predominantly from cardiovascular disease. Increased free radical activity and abnormalities in hemostasis have been implicated in the development of vascular disease. Therefore, we measured markers of free radical activity (nonperoxide-conjugated diene isomer of linoleic acid [PL-9,11-LA'] and lipid peroxides expressed as malondialdehyde [MDA]) along with the hemostatic variables: fibrinogen, von Willebrand factor (vWf), plasminogen activator inhibitor (PAI-1), tissue plasminogen activator (t-PA), and plasmin activity (B beta 15-42) in 24 NIDDM patients (12 patients with microalbuminuria and 12 without microalbuminuria) and in 12 age-matched control subjects. There were no differences in linoleic acid (PL-9,12-LA) concentrations between the three groups. PL-9,11-LA' was elevated in the microalbuminuric patients compared with control subjects (P less than 0.05), but there was no difference between the two diabetic groups. MDA was elevated in the microalbuminuric diabetic patients compared with those patients without microalbuminuria (P less than 0.05) and control subjects (P less than 0.001). MDA was also increased in the patients without microalbuminuria compared with control subjects (P less than 0.01). Except for B beta 15-42, all the hemostatic variables were increased (P less than 0.05) in the diabetic patients compared with control subjects. The microalbuminuric diabetic patients had further increases in vWf (P less than 0.03) and t-PA (P less than 0.03) compared with patients with microalbuminuria. Our study suggests that there is an increase in free radical activity and abnormalities in hemostatic variables favoring a hypercoagulable state in NIDDM, especially in those with microalbuminuria.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Clinical Chemistry, Gartnavel General Hospital, Glasgow, UK.
authors.forename: A
authors.initials: A
authors.lastname: Collier
authors.forename: A
authors.initials: A
authors.lastname: Rumley
authors.forename: A G
authors.initials: AG
authors.lastname: Rumley
authors.forename: J R
authors.initials: JR
authors.lastname: Paterson
authors.forename: J P
authors.initials: JP
authors.lastname: Leach
authors.forename: G D
authors.initials: GD
authors.lastname: Lowe
authors.forename: M
authors.initials: M
authors.lastname: Small
mesh_terms: D000328:Adult; D000368:Aged; D000419:Albuminuria / Q000097:blood* / Q000209:etiology; D000704:Analysis of Variance; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation / Q000502:physiology*; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications*; D003925:Diabetic Angiopathies / Q000209:etiology; D003928:Diabetic Nephropathies / Q000097:blood*; D005609:Free Radicals / Q000378:metabolism*; D006801:Humans; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000097:blood; D008315:Malondialdehyde / Q000097:blood; D008875:Middle Aged; D012044:Regression Analysis
chemical_list: D015415:Biomarkers; D005609:Free Radicals; D008041:Linoleic Acids; D008315:Malondialdehyde; D019787:Linoleic Acid